World News

Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes

Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes (MedPage Today) — CHICAGO — An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found.
Among 559 participants in ACHIEVE…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button